磁性纳米材料在生物医学领域的应用

从靶向药物载体技术,细胞分离技术,免疫分析,酶的吸附与固定作用和基因治疗几个方面简要分析磁性纳米材料在生物医学领域的应用及其发展过程中有待解决的问题。  

生物医学成像的若干发展动向

本文综述了近年来生物医学成像的发展动向.文章指出随着基因组学、分子与细胞生物学的发展,小动物成像的研究方兴未艾,微型CT、微型PET、微型MRI,前景诱人.图象引导的介入治疗仍是研究热点,着重于研究术中组织变形后的图象配准与实时治疗监护.所有的成像技术都朝提高灵敏度、空间分辨力与时间分辨力的方向努力.细胞成像、分子成像已引起注意.多种模式结合在一起的成像装置更引起人们极大的兴趣.磁共振成像朝快速获取数据的方向努力以便做成实时高分辨力MRI.磁共振弹性图和扩散张量成像的应用研究十分活跃.CT研究有新局面:锥束螺旋CT、倒置CT等即将走出实验室,4DCT已见初样.  

生物医学工程学科在临床中的创新应用

介绍了生物医学工程学科的概念，讨论了生物医学工程学科的学科优势及其在临床中的常规应用，并举例探讨了生物医学工程学科医工结合的专业特色及其在临床中的创新应用，提出了未来生物医学工程学科的发展建议。  

骨科生物力学参数测试理论及方法研究进展

介绍了骨生物力学参数测试理论近年来的发展,同时对骨生物力学参数测试方法以及相应测试设备的测试原理、优缺点及国内外研究现状进行了详细介绍。最后,展望了其未来的研究方向。  

Non-biomedical health care practices in the State of Morelos, Mexico: analysis of an emergent phenomenon

This paper gives the results of one of the first studies of non-biomedical health care services in the State of Morelos, Mexico. The socio-cultural matrix of the population of Morelos has attracted many practitioners of medical models which have no foundation in the rationale of the biomedical-scientific model. There is a considerable variety of non-biomedical therapists in the area of study which may be categorised in three groups: (a) traditional medicine (b) alternative medicine, and (c) faith healing. There are marked differences regarding the academic background of practitioners, the reasons why they engage in their practice, the types of financial strategies they use to provide care, the creation and utilisation of therapist networks, and, finally, in the type of population for whom they provide care. We strongly recommend further research on non-biomedical health care models in the state and in Mexico, since the importance of these models is growing as a result of the increasing demand for health care by a diversity of population groups.  

国内生物医药信息服务平台现状浅析与展望

随着卫生信息化的推进,生物医药信息服务平台相继建成并投入使用。本研究通过网页浏览,查询到23个生物医药信息服务平台,浅析各平台投入使用年代、地理分布、提供服务类别等现状,分析了各平台提供成果转化服务的模式。讨论了国内生物医药信息服务平台存在的问题,对未来生物医药信息服务平台发展进行了展望。  

我国生物医学伦理审查中应关注的几个要点

本文结合华西医院伦理管理工作,认真探讨了我国生物医学伦理审查中应关注的几个要点,包括调查与实验、新项目与常规项目、补偿与赔偿,以及生物医学伦理审查等内容,旨在为我国生物医学伦理管理工作的建设与发展提供良好的借鉴。  

Hybrid bodies and the materiality of everyday life: how people living with pacemakers and defibrillators reinvent everyday routines and intimate relations

Technologies inside bodies pose new challenges in a technological culture. For people with pacemakers and defibrillators, activities such as passing security controls at airports, using electromagnetic machines, electrical domestic appliances and electronic devices, and even intimate contacts with their loved ones can turn into events where the proper functioning of their device may be at risk. Anticipation of potentially harmful events and situations thus becomes an important part of the choreography of everyday life. Technologies inside bodies not only pose a challenge for patients living with these devices but also to theorising body‐technology relations. Whereas researchers usually address the merging of bodies and technologies, implants ask us to do the opposite as well. How are we to understand human‐technology relations in which technologies should not entangle with bodies because they serve other purposes? Based on a study of the daily life practices of people with pacemakers and defibrillators in the Netherlands and the US, I argue that disentanglement work, i.e. work involved to prevent entanglements with objects and people that may inflict harm upon implanted devices, is key to understanding how hybrid bodies can survive in today's densely populated technological landscape.  

The sociology of cancer: a decade of research

Biomedicine is often presented as the driving force behind improvements in cancer care, with genomics the latest innovation poised to change the meaning, diagnosis, treatment, prevention and lived experience of cancer. Reviewing sociological analyses of a diversity of patient and practitioner experiences and accounts of cancer during the last decade (2007–17), we explore the experiences of, approaches to and understandings of cancer in this period. We identify three key areas of focus: (i) cancer patient experiences and identities; (ii) cancer risk and responsibilities and (iii) bioclinical collectives. We explore these sociological studies of societal and biomedical developments and how sociologists have sought to influence developments in cancer identities, care and research. We end by suggesting that we extend our understanding of innovations in the fields of cancer research to take better account of these wider social and cultural innovations, together with patients, activists' and sociologists' contributions therein.